gliadin

Botanicalexperimental

Gliadin is a class of proteins present in wheat and several other cereals within the grass genus Triticum. Gliadins, which are a component of gluten, are essential for giving bread the ability to rise properly during baking. Gliadins and glutenins are the two main components of the gluten fraction of the wheat seed. This gluten is found in products such as wheat flour. Gluten is split about evenly between the gliadins and glutenins, although there are variations found in different sources. — Wikipedia

Clinical trial activity

5 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
1

Earliest trial started Apr 1, 2016 (NCT02753582)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • GlutenImmunity, desensitized

    Gluten immunity, desensitized

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • gliadin
  • gliadin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03941808N/AJun 2, 2019University of Nice Sophia Antipolis
NCT03878433N/AApr 1, 2019University of Nice Sophia Antipolis
NCT03738475Phase 2Jan 4, 2019Cour Pharmaceutical Development Company, Inc.
NCT03486990Phase 1Feb 9, 2018Cour Pharmaceutical Development Company, Inc., Harvard University
NCT02753582Phase 4Apr 1, 2016University of Indonesia
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cour Pharmaceutical Development Company, Inc.For profit2222018
University of Nice Sophia AntipolisAcademic/Hospital2212019
Harvard UniversityAcademic/Hospital1012018
University of IndonesiaAcademic/Hospital1112016
4 organizations
Page 1 / 1